Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Source filing unavailable
Q4 2013 · —
Revenue$3.47B$3.47B+6.4% vs Q4 2012 Net Income$342.10M$342.10M−9.1% vs Q4 2012 EPS Diluted$0.92$0.92−11.5% vs Q4 2012 Gross Profit$1,481,700,000+6.9% Operating Incomederived$455,000,000+13.6% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$728,500,000+10.4% Free Cash Flowderived$634,000,000+14.1% Margins · derivedGross margin42.7%+0.2 pt vs Q4 2012
Operating margin13.1%+0.8 pt vs Q4 2012
Net margin9.9%−1.7 pt vs Q4 2012